RHYTHM PHARMACEUTICALS, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RHYTHM PHARMACEUTICALS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $1.25M, a 46.49% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $729.00K, a 22.11% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $854.00K, a 26.89% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-09-30 was $597.00K, a 53.87% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $1.58M, a 24.72% increase from fiscal 2024.
- RHYTHM PHARMACEUTICALS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $1.27M, a 20.61% increase from fiscal 2023.
- RHYTHM PHARMACEUTICALS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $1.05M, a 68.21% increase from fiscal 2022.
- RHYTHM PHARMACEUTICALS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $626.00K, a 0.81% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $1.25M 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $1.58M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $729.00K 10-Q · filed 2025-11-04 | |
| 2025-03-31 | $854.00K 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $1.27M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $597.00K 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $673.00K 10-Q · filed 2025-11-04 | |
| 2023-12-31 | $1.05M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $388.00K 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $665.00K 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $626.00K 10-K · filed 2025-02-28 | |
| 2022-09-30 | $227.00K 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $399.00K 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $621.00K 10-K · filed 2024-02-29 | |
| 2021-09-30 | $233.00K 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $388.00K 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $522.00K 10-K · filed 2023-03-01 | |
| 2020-09-30 | $198.00K 10-Q · filed 2021-11-02 | |
| 2020-03-31 | $324.00K 10-Q · filed 2021-11-02 | |
| 2019-12-31 | $558.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | $263.00K 10-Q · filed 2020-11-02 | |
| 2019-03-31 | $295.00K 10-Q · filed 2020-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |